Authors


Charles L. Raison, MD

Latest:

Inflammation and Treatment Resistance in Major Depression: The Perfect Storm

New findings provide powerful evidence that inhibition of inflammation or its downstream effects on mood may open up a host of new approaches to treatment for depression, especially for patients with treatment-resistant depression.


Charles L. Scott, MD

Latest:

Forensic Issues in Child Sexual Abuse Allegations

When sexual abuse is alleged, children may face investigative interviews, family disruptions, a change in their school environment, mental health counseling, and even trial court testimony.


Charles Nguyen, MD

Latest:

Implementation of a Diet Program for Inpatients With Schizophrenia

Weight gain is a major concern in patients with schizophrenia, especially in those taking atypical antipsychotics. Although the exact mechanism of weight gain associated with atypical antipsychotics is unknown, we often hear patients complain about an increase in appetite and a decrease in satiety.


Charles P. O'Brien, MD, PhD

Latest:

Psychotherapy with Opioid-Dependent Patients

Psychotherapy as a sole treatment for noncoerced opioid addicts in outpatient settings has been shown to have little patient interest and low chances for success. However, when integrated into a treatment plan that includes methadone maintenance and drug counseling, it can be associated with additional benefits for patients who have moderate to severe levels of psychiatric symptoms.


Charles Portney, MD

Latest:

Intergenerational Transmission of Trauma: An Introduction for the Clinician

Parents who have witnessed traumatic events may pass dysfunctional life views on to their children. How much more vulnerable are these second-generation victims to PTSD and other psychiatric disorders?


Charles R. Conway, MD

Latest:

Neurostimulation Treatments in Psychiatry: An Overview and Recent Advances

There have been considerable advances in the research on and clinical use of neurostimulation for psychiatric disorders, especially mood disorders and MDD. Three of the most recognized are reviewed here. An experimental new treatment-- trigeminal nerve stimulation-- is also briefly discussed.


Charles R. Figley, PhD

Latest:

Treatment of Military Populations

What psychiatric illnesses are most prevalent among veterans? And how can clinicians help them overcome obstacles to care?


Charles R. Joy, MD

Latest:

The Dialogue Between Science and Art

In a variety of creative fields, psychiatrists have been portrayed in many ways. This Special Report is psychiatry's turn to address creativity with offerings as diverse as the creative arts themselves. From Shakespeare to rock 'n' roll, there's something for everyone.


Charles Raison, MD

Latest:

Introduction: The Inflammation Connection

This 2-part Special Report devotes itself to the new inflammatory world that clinicians and researchers find themselves in. Most of our prior and current preconceptions about the role of immunity and mental illness have been-and are-wrong.


Charles T. Nguyen, MD

Latest:

Bipolar Disorder: Increasing the Effectiveness and Decreasing the Side Effects of Treatment

Studies have shown that many pharmacologic agents are effective in the treatment of acute mania and bipolar relapse education.


Charles W. Mathias, PhD

Latest:

The Conceptualization and Role of Impulsivity: Bipolar Disorder and Substance Abuse

Impulsive behaviors play an important role in both bipolar and substance abuse disorders. However, results of studies investigating this link are often ambiguous, in part, due to the multidimensional nature of the impulsivity construct and the fact that many studies use a single measurement technique. We describe a model of impulsivity characterized by three components: response initiation, response inhibition and consequence sensitivity. How these components differ from one another in terms of their use, behavioral theory and biological function is discussed, along with measurement techniques.


Charlotte L. Haley, PhD

Latest:

Continuation Treatment and Relapse Prevention in Pediatric Depression

The prevalence of depression in children and adolescents ranges from 2% to 8% in the general population, which indicates that depression in this population is a major public health concern.1-3 This is especially apparent when rates of depression are compared with other serious medical conditions in childhood, such as diabetes, which has a prevalence of 0.18%.4 The burden of depressive illness-including significant functional impairment in interpersonal relationships, school, and work-on the developing child has been well documented. Affected youths are frequently involved in the juvenile justice system.5-8 Furthermore, adolescents with depression are at increased risk for substance abuse, recurrent depression in adulthood, and attempted or completed suicide.3,9-15


Cheryl K. Olson, ScD

Latest:

Children and Video Games: How Much Do We Know?

There is no shortage of hyperbole when politicians of all stripes describe the nature and effects of video games. Republican presidential candidate Mitt Romney proclaimed, "Pornography and violence poison our music and movies and TV and video games.


Chetan Haldipur, MD

Latest:

Unhinged: The Trouble With Psychiatry-A Doctor’s Revelations About a Profession in Crisis

Unhinged is one of many books published in the past few years critical of psychiatry. A book of scandals and debates, and a polemic of sorts-a “trahison des clercs”-rather than an intellectual discussion about psychiatry. Therein lies the trouble with psychiatry.


Chiara Fabbri, MD

Latest:

6 Signs Your Patient Is at Risk for Treatment-Resistant Depression

What factors predispose patients to TRD and what treatment strategies achieve response? Find out here, with a bonus case vignette.


Chiara Rafanelli, MD

Latest:

Depression, Stress and the Risk of Heart Disease

In recent years, depression and stress have emerged in the discussion of the impact of psychosocial aspects on coronary heart disease. Several studies indicate that these factors result in risk elevation comparable to hypercholesterolemia and hypertension.


Chih-chiang Chiu, MD

Latest:

The Use of Omega-3 Fatty Acids in Treatment of Depression

This review provides an overview of the efficacy, safety, and mechanisms of action in the treatment of depression.


Chloe Campbell, PhD

Latest:

Trait Stages of Diagnosis for Borderline Personality Disorder

The authors describe an alternative model for BPD diagnosis that is dimensional in nature and requires fulfillment of 4 of 7 personality traits.


Chris Aiken, MD

Latest:

New Directions for Insomnia and Bipolar Disorder

The average patient with bipolar disorder struggles with sleep disorders. Here's how you can help.


Chris Bullen, MBChB, MPH, PhD

Latest:

The Role of Electronic Cigarettes for Tobacco Dependence Treatment

Stopping smoking affects the metabolism of a number of drugs used in the management of mental illness. Here, a summary of the author's published study on whether e-cigarettes with nicotine were more effective for smoking cessation than nicotine patches.


Chris Candler, MD

Latest:

In Support of Early Psychotherapy Training

Recent reports have noted an alarming decrease in the practice of psychotherapy among psychiatrists.


Chris E. Stout, PsyD

Latest:

Fee Agreements: What Works, What Doesn’t- and How to Use Them

This article reviews the many forms of fee agreement and notes the important factors to consider as well as questions to ask to properly assess and vet what may be best for one’s practice.


Chris Fitzpatrick, MD

Latest:

Scene From The Fall: Mental Ward US Military Hospital, Nuremberg, Germany

Here we present an excerpt from a screenplay to commemorate the 70th anniversary of the liberation of the concentration camps.


Chris Gordon, MD

Latest:

Scared of Heights

I am scared of heights. As a psychiatrist, it’s faintly embarrassing to have such a phobia-but given that I live in a Boston suburb, not the Rockies, it’s a problem that hardly ever comes up. Ski lifts and I don’t get along all that well, but other than that, I barely ever think of this as an issue in my life.


Chris Lang, MD

Latest:

Climate Change and Mental Health

The effects of climate change are severe and global, affecting world economies, triggering migrations and wars, and having profound effects on mental and physical health.


Christen E. Dressel, MA

Latest:

Treating Complex Trauma Survivors

This CME outlines distinguishing features of PTSD, complex trauma, and the dissociative subtype of PTSD (DPTSD), with an explanation of the distinctive neurobiological subtype of DPTSD.


Christian J. Nelson, PhD

Latest:

Cognitive Impairment in Patients Receiving Cancer Chemotherapy

Anxiety and depression are the most often cited problems related to a cancer diagnosis, because receiving this diagnosis is often very frightening. Feeling sad, worrying relentlessly, and being unable to experience pleasure often lead people to feel that they may be on the path to losing their minds. However, in the past few years a more subtle phenomenon has been identified related to cognitive deficits allegedly associated with chemotherapy treatment, sometimes called chemobrain.


Christina Brezing, MD

Latest:

Treatment for Cannabis Use Disorders: A Case Report

It is vital that psychiatrists are able to identify and characterize cannabis use disorders; provide education; and offer effective, evidence-based treatments. This article provides a brief overview of each of these topics.


Christina C. Sanchez, MA

Latest:

Cognitive-Behavioral Therapy for Adolescent DepressionProcesses of Cognitive Change

The substantial and often recurrent distress and impairment associated with major depressive disorder (MDD) in youth has prompted increased interest in the identification and dissemination of effective treatment models. Evidence supports the use of several antidepressant medications, specific psychotherapies, and, in the largest treatment study of depressed teenagers, the combination of fluoxetine and cognitive-behavioral therapy (CBT) as effective treatments.1-3 CBT is the most extensively tested psychosocial treatment for MDD in youth, with evidence from reviews and meta-analyses that supports its effectiveness in that population.3-5


Christina E. Wierenga, PhD

Latest:

Neurobiology of Eating Disorders: Clinical Implications

New insights into neural pathways that play a role in anorexia nervosa, bulimia nervosa, and binge eating disorder.

© 2024 MJH Life Sciences

All rights reserved.